. Author manuscript; available in PMC: 2015 Dec 1.

Published in final edited form as: Lupus. 2014 Jul 23;23(14):1460–1467. doi: 10.1177/0961203314543915

Table 2.

Frequency of disease manifestations by presence of flare at baseline and baseline C-reactive protein (n=176)^a

	Baseline Active Disease/Flare			Baseline C-reactive Protein (μg/ml)

	Yes n=101 n (%)	No n=72 n (%)	χ² p-value	< 3 n=57 n (%)	3 - <10 n=71 n (%)	> 10 n=48 n (%)	χ² p-value
Lupus nephritis^b	23 (22)	19 (26)	0.6	15 (26%)	16 (23%)	11 (23%)	0.9
Anti-dsDNA+	54 (59)	43 (64)	0.5	37 (69%)	42 (66%)	20 (47%)	0.06
Serositis	47 (48)	29 (41)	0.4	23 (41%)	26 (38%)	27 (59%)	0.07
Arthritis	79 (80)	46 (65)	0.03	39 (70%)	53 (76%)	36 (77%)	0.6

data on baseline active disease/flare missing for n=3 patients;

data missing for anti-dsDNA (n=15), serositis (n=5), and arthritis (n=3);